- Three employees at the Department of Veterans Affairs have been indicted for accepting bribes from the pharmaceutical firm MiMedx.
- The company is helmed by the flamboyant so-called Trump of Georgia, Pete Petit, who chaired the president's finance committee in the state.
- Petit has been at war with Wall Street short sellers for months, suing them for alleging accounting malfeasance at the company.
3 VA employees were just indicted for accepting bribes from the 'Trump of Georgia's' pharmaceutical firm
VA employees have been indicted for accepting thousands of dollars, trips, and other gifts from, MiMedx It is a pharmaceutical firm helmed by Pete Petit, who chaired Donald Trump's finance committee in Georgia.
Three employees at the Department of Veterans Affairs have been indicted for accepting bribes from a
The company is helmed by Trump campaign finance chair and so-called Trump of Georgia, Pete Petit. He's known for flying planes and hanging out with
The VA employees — Donna Becker, Marcela Dolores Ferrer, and Garol Guardiola — were indicted for accepting thousands of dollars from MiMedx for pushing its wound-care product at the Department of Veterans Affairs and committing healthcare fraud. They also got vacations, free meals, and stock in the company.
In a statement, MiMedx simply said that the company itself has not been indicted.
So Petit went on a rampage suing random shops on Wall Street to try to smoke out the identities of the individuals behind the reports. He attacked them online, the shorts attacked back. When Business Insider wrote a story about this messy situation,
The SEC is, by the way, investigating MiMedx for channel stuffing. The Justice Department is also looking into its business practices, according to Bloomberg.
Business Insider sent MiMedx a bunch of additional questions about the investigation. Back in September, MiMedx said it was not the target of any investigation. Again, in its statement this week, it said that it had not been indicted. We asked MiMedx if Petit knew of any wrongdoing at the company, if it was in fact the target of an investigation at this point, and if it's possible that more individuals from the VA may be indicted for a similar relationship with MiMedx.
At the time of this publication we have yet to hear back from the company.